InnoCan Pharma Corporation (CSE:INNO)

Canada · Delayed Price · Currency is CAD

6.32

-0.91 (-12.59%)

Feb 6, 2026, 11:40 AM EST

Revenue by Product

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Online Sales	40.28M
Online Sales Growth	120.26%
Other	52.06K
Other Growth	-64.61%

Revenue by Geography

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	40.28M
United States Growth	120.26%
Rest of the World	52.06K
Rest of the World Growth	-64.61%